Dilantha B. Ellegala, MD, FAANS Joins the Newly Created Advisory Board of Xcelerate, Inc.

Rhea-AI Summary

Xcelerate, Inc. (OTC: UDHI) has appointed Dr. Dilan Ellegala to its Advisory Board, effective immediately. Dr. Ellegala is a distinguished neurosurgeon and medical innovator with extensive experience in med-tech commercialization. He has held significant academic roles, authored over 50 research publications, and founded successful medical companies, including Sonospine LLC. CEO Michael O'Shea expressed that Dr. Ellegala’s expertise will be pivotal in advancing Xcelerate’s business development and acquisition efforts, marking an important transition for the company.

Positive

• Dr. Dilan Ellegala's appointment brings extensive experience in med-tech commercialization and clinical care.
• Dr. Ellegala has founded successful medical companies, suggesting strong entrepreneurial capabilities.
• The addition of Dr. Ellegala may strengthen Xcelerate's position in future acquisition and product development efforts.

Negative

• None.

MAULDIN, S.C., Feb. 8, 2021 /PRNewswire/ -- Xcelerate, Inc. (OTC: UDHI) is pleased to announce that Dr. Dilan Ellegala has accepted an invitation to join its Advisory Board, effective immediately. A University of Virginia trained neurosurgeon and former Harvard Clinical Instructor, Dr. Ellegala is an academician, medical inventor, and entrepreneur, with in-depth knowledge of med-tech commercialization.

Dr. Ellegala has been at the forefront of clinical care and medical technology development for two decades. An honors graduate of the University of Washington School of Medicine, he served academic leadership roles as Director of Neurotrauma and Cerebrovascular Neurosurgery at major universities, a founding Dean for Global Health, and has had collaborations with the Wellman Center for Photomedicine at MIT/Harvard, Clemson Bioengineering, and private industry. He has authored over 50 peer reviewed research publications and holds multiple patent claims in ultrasound technology. Dr. Ellegala has successfully commercialized medical technology and applied it to advance clinical care. He has founded several successful medical companies including Sonospine LLC, a pioneer in ultrasonic spine surgery, and a virtual health company recently acquired by AdviNOW, LLC which applies artificial intelligence to healthcare.

Dr. Ellegala has received numerous academic and clinical honors and has been consistently recognized for his excellence in patient care. In addition to his pioneering work in the US, he is a testament to the transformational power of teaching and the ever-present potential for change in the world, as demonstrated through his training of health care workers in remote Tanzania to perform brain and spine surgery. His groundbreaking work in global medical education is documented in the book, "A Surgeon in the Village: An American Doctor Teaches Brain Surgery in Africa", which was written by Pulitzer-nominated journalist Tony Bartleme. NBC's Tom Brokaw described the work as "A lyrical, inspirational and altogether rewarding account of first- and third-world surgeons working together to perform neurosurgery miracles in the heart of Africa."

"This is truly a great day for Xcelerate," said Michael O'Shea, Xcelerate's CEO. "Adding a world class surgeon and medical technology innovator with incredible business savvy and people skills to our Advisory Board is exactly what we've been seeking to transition to our next phase of business development. Dr. Ellegala is a true humanitarian who is blessed with an abundance of innate goodness. I am honored to have him join our team and look forward to utilizing all of his extraordinary talents and abilities to aide us in our ongoing acquisition and product development efforts."

To interview either Dr. Ellegala or O'Shea, contact Dilara Tuncer at 941-549-3571; dilara@transmediagroup.com.

SAFE HARBOR

This press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), including all statements that are not statements of historical fact regarding the intent, belief or current expectations of the Company, its directors or its officers with respect to, among other things: (i) the Company's financing plans; (ii) trends affecting the Company's financial condition or results of operations; (iii) the Company's growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend," and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors.

 

View original content:http://www.prnewswire.com/news-releases/dilantha-b-ellegala-md-faans-joins-the-newly-created-advisory-board-of-xcelerate-inc-301223474.html

SOURCE Xcelerate, Inc.

FAQ

Who is Dr. Dilan Ellegala and what expertise does he bring to Xcelerate?

Dr. Dilan Ellegala is a distinguished neurosurgeon and medical inventor with extensive experience in med-tech commercialization and clinical care. He has held significant academic leadership roles and founded successful medical companies.

What is the significance of Dr. Ellegala joining Xcelerate's Advisory Board?

His appointment is expected to strengthen Xcelerate's business development and acquisition efforts, marking a critical transition for the company.

What is the ticker symbol for Xcelerate, Inc.?

The ticker symbol for Xcelerate, Inc. is UDHI.

When was the announcement made regarding Dr. Ellegala's appointment?

The announcement was made on February 8, 2021.